Transgene is designing and developing next-generation immunotherapeutics against cancer

–> article annonceHome

Innovative technologies

Push the boundaries of immunotherapy

Transgene combines cutting-edge technologies, a multidisciplinary team and a prestigious international network.

Discover our technologies

 

One patient, one cancer, one vaccine

With myvac®, Transgene enters the field of individualized immunotherapies with a unique virus-based immunotherapy platform.

myvac® video Discover myvac®

A new generation of products

These innovative multifunctional OVs are able to modulate the tumor micro-environment to better attack cancer.

Discover invir.IO

TG4001

A therapeutic vaccine in Phase II

TG4001 targets HPV-induced anogenital cancers.

More information

–> article Home actus

Two therapeutic approaches

Transgene’s immunotherapies harness the mechanisms of the immune response to enable the patient’s body to fight against disease. 

Press releases

See all press releases



Last publications

See all publications



Latest webcasts

A pioneer in viral vectors engineering, we have one ambition: design innovative treatments in the fight against cancer.

Transgene sa
400 Boulevard Gonthier d’Andernach - Parc d'Innovation - CS80166
67405 Illkirch Graffenstaden Cedex - France |
Tel. : + 33 (0) 3 88 27 91 00

 

© 2021 Transgene - All rights reserved
Terms of use - Credits